Companies / ALX Oncology Holdings Inc.
ALX Oncology Holdings Inc.
Nasdaq: ALXOCIK 1810182SOUTH SAN FRANCISCO, CA
Financials · FY2022
Ownership
138.3M shares outstanding · as of Jul 30, 2026
Ownership
| Insiders | 6.39% | 8,833,452 |
| Institutions | 47.28% | 65,372,586 |
| Public float | 46.34% | 64,070,959 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 10
View all →| Insider | % of shares | Shares |
|---|---|---|
Goodman Corey SDirector · 10% owner | 6.11% | 8,453,038 |
Lettmann JasonCEOCHIEF EXECUTIVE OFFICER · Director | 0.21% | 293,609 |
Pinto ShellySVP, FINANCE AND CAO | 0.06% | 86,805 |
Curran Daniel J.Director | — | — |
Garland J. ScottDirector | — | — |
Hemrajani RekhaDirector | — | — |
Klencke BarbaraChief Medical Officer | — | — |
Sandler Alan B.Director | — | — |
Shantharam HarishChief Financial Officer | — | — |
Takimoto Chris HDirector | — | — |
Institutional holders 66
View all →| Holder | Value | % of shares |
|---|---|---|
| $26.09M | 9.41% | |
| $15.32M | 5.35% | |
| $11.71M | 4.21% | |
| $10.96M | 7.01% | |
| $7.51M | 2.72% | |
| $5.75M | 2.07% | |
| $4.01M | 1.45% | |
| $3.99M | 1.44% | |
| $3.69M | 2.36% | |
| $3.18M | 1.15% |
Activity
Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q1 2026 as of | RA Capital Management, L.P. 13F manager | New | — | $26.09M | +13.0M | 13,011,849 9.41% of shares | medium |
| Q2 2026 as of | BlackRock, Inc. 13F manager | Add | — | $14.38M | +6.9M +1542.77% | 7,399,530 5.35% of shares | medium |
| Q1 2026 as of | Blackstone Inc 13F manager | New | — | $11.71M | +5.8M | 5,826,544 4.21% of shares | medium |
| Q1 2026 as of | Marshall Wace, LLP 13F manager | Add | — | $7.46M | +3.7M +14144.83% | 3,757,216 2.72% of shares | medium |
| Q1 2026 as of | Orbimed Advisors LLC 13F manager | New | — | $5.75M | +2.9M | 2,866,256 2.07% of shares | medium |
| Q1 2026 as of | Adage Capital Partners Gp, L.L.C. 13F manager | New | — | $4.01M | +2.0M | 2,000,000 1.45% of shares | low |
| Q2 2026 as of | State Street Corporation 13F manager | Add | — | $2.85M | +1.4M +1106.58% | 1,498,905 1.08% of shares | low |
| Q1 2026 as of | Millennium Management LLC 13F manager | Trim | — | $-2.44M | -1.2M -37.95% | 1,988,559 1.44% of shares | low |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| RA Capital Management, L.P. | Passive13G | — |
| TCG Crossover GP II, LLC | Passive13G | — |
| HBM Healthcare Investments (Cayman) Ltd. | Passive13G/A | — |
| Millennium Management LLC | Passive13G/A | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| ALXO | — | 00166B105 |